PT  - JOURNAL ARTICLE
AU  - Joshi, Keya
AU  - Kahn, Rebecca
AU  - Boyer, Christopher
AU  - Lipsitch, Marc
TI  - Some principles for using epidemiologic study results to parameterize transmission models
AID  - 10.1101/2023.10.03.23296455
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.10.03.23296455
4099  - http://medrxiv.org/content/early/2023/10/03/2023.10.03.23296455.short
4100  - http://medrxiv.org/content/early/2023/10/03/2023.10.03.23296455.full
AB  - Background Infectious disease models, including individual based models (IBMs), can be used to inform public health response. For these models to be effective, accurate estimates of key parameters describing the natural history of infection and disease are needed. However, obtaining these parameter estimates from epidemiological studies is not always straightforward. We aim to 1) outline challenges to parameter estimation that arise due to common biases found in epidemiologic studies and 2) describe the conditions under which careful consideration in the design and analysis of the study could allow us to obtain a causal estimate of the parameter of interest. In this discussion we do not focus on issues of generalizability and transportability.Methods Using examples from the COVID-19 pandemic, we first identify different ways of parameterizing IBMs and describe ideal study designs to estimate these parameters. Given real-world limitations, we describe challenges in parameter estimation due to confounding and conditioning on a post-exposure observation. We then describe ideal study designs that can lead to unbiased parameter estimates. We finally discuss additional challenges in estimating progression probabilities and the consequences of these challenges.Results Causal estimation can only occur if we are able to accurately measure and control for all confounding variables that create non-causal associations between the exposure and outcome of interest, which is sometimes challenging given the nature of the variables we need to measure. In the absence of perfect control, non-causal parameter estimates should still be used, as sometimes they are the best available information we have.Conclusions Identifying which estimates from epidemiologic studies correspond to the quantities needed to parameterize disease models, and determining whether these parameters have causal interpretations, can inform future study designs and improve inferences from infectious disease models. Understanding the way in which biases can arise in parameter estimation can inform sensitivity analyses or help with interpretation of results if the magnitude and direction of the bias is understood.Competing Interest StatementCB has no conflicts of interest to disclose. KJ is an employee of Moderna Inc., and holds stock/stock options in the company. RK reports consulting fees from the Pan American Health Organization. ML received consulting fees from Janssen.Funding StatementKJ was supported by NIH Training Grant T32AI007535. This work was supported by the U.S. National Cancer Institute SeroNet cooperative agreement U01CA261277 and by a subcontract from US NIH grant R01GM139926.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesNo code was used in this paper.